Abound Wealth Management’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138 Hold
3
﹤0.01% 1215
2026
Q1
$198 Sell
3
-3
-50% -$157 ﹤0.01% 1242
2025
Q4
$254 Hold
6
﹤0.01% 1102
2025
Q3
$253 Hold
6
﹤0.01% 1049
2025
Q2
$332 Sell
6
-100
-94% -$4.98K ﹤0.01% 903
2025
Q1
$6.04K Sell
106
-12
-10% -$749 ﹤0.01% 499
2024
Q4
$8.19K Hold
118
﹤0.01% 431
2024
Q3
$16.1K Hold
118
0.01% 330
2024
Q2
$16K Hold
118
0.01% 294
2024
Q1
$20.3K Hold
118
0.01% 246
2023
Q4
$18.4K Hold
118
0.01% 278
2023
Q3
$14.9K Buy
118
+34
+40% +$4.18K 0.01% 264
2023
Q2
$9.77K Buy
84
+66
+367% +$7.15K ﹤0.01% 338
2023
Q1
$1.96K Hold
18
﹤0.01% 590
2022
Q4
$1.84K Hold
18
﹤0.01% 550
2022
Q3
$1.63K Buy
+18
New +$1.98K ﹤0.01% 522

Other funds holding CE

Abound Wealth Management's CE Position: Q2 2026 in Review

Abound Wealth Management held its Celanese (CE) position steady in Q2 2026 at 3 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Abound Wealth Management first reported a position in CE in Q3 2022 and has held it in 16 quarters since. The position peaked at $20.3K in Q1 2024. 74 funds tracked by Wall St. Rank hold CE as of Q2 2026.

  • Abound Wealth Management held 3 shares of Celanese worth $138 as of Q2 2026.
  • Abound Wealth Management left its Celanese share count unchanged in Q2 2026.
  • Celanese made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1215 holding.
  • Abound Wealth Management first reported a position in Celanese in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Celanese position peaked at $20.3K in Q1 2024.
  • 74 funds tracked by Wall St. Rank held Celanese as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.